Cotinga Pharmaceuticals SMA 50
What is the SMA 50 of Cotinga Pharmaceuticals?
The SMA 50 of Cotinga Pharmaceuticals, Inc. is CAD$0 +99.81%
What is the definition of SMA 50?
SMA 50 is an average stock price from the last 50 days calculated as an unweighted mean of the previous 50 stock closing prices.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 of companies in the Health Care sector on TSXV compared to Cotinga Pharmaceuticals
What does Cotinga Pharmaceuticals do?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Companies with sma 50 similar to Cotinga Pharmaceuticals
- Tintina Mines has SMA 50 of CAD$0 +67.00%
- Bold Ventures has SMA 50 of CAD$0 -32.22%
- Blockmint Technologies has SMA 50 of CAD$0 +0.78%
- Olivut Resources has SMA 50 of $0 -32.32%
- Freeport Resources has SMA 50 of $0 -20.66%
- WMCH Global Investment has SMA 50 of HKD$0 -32.35%
- Cotinga Pharmaceuticals has SMA 50 of CAD$0 +99.81%
- Eurosport Active World has SMA 50 of $0 -130.25%
- WWPKG has SMA 50 of HKD$0 -15.13%
- Wai Hung has SMA 50 of HKD$0 -75.27%
- Gibb River Diamonds has SMA 50 of AUD$0 -11.98%
- Sassy Resources has SMA 50 of $0 +64.92%
- Orefinders Resources has SMA 50 of $0 -8.82%